Abiopharma

🔍 WANG CHUN KAI (Director)

Company: OBOOK HOLDINGS INC. (OWLS)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 758 shares of Class A Common Shares at $5.1806 per share (Direct)
  Date: 2026-09-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,113,208.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 11,600 shares of Class A Common Shares at $5.0085 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,124,808.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average price of US$5.1806. These shares were purchased in multiple transactions at prices ranging from US$5.0899 to US$5.2496, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
• F2: The price reported in Column 4 is a weighted average price of US$5.0085. These shares were purchased in multiple transactions at prices ranging from US$4.9850 to US$5.0347, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.